CONMED CORPORATION Treasury Stock, Common, Value
CONMED CORPORATION (CNMD) had Treasury Stock, Common, Value of $54.68 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Treasury Stock, Value
us-gaap:TreasuryStockCommonValue · last filed 2026-07-29
- 2026-06-30: Treasury Stock, Common, Value $54.68M.
- 2025-12-31: Treasury Stock, Common, Value $12.89M.
- 2025-09-30: Treasury Stock, Common, Value $13.52M.
- 2025-06-30: Treasury Stock, Common, Value $13.86M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $54.68M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $12.89M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $13.52M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $13.86M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $14.51M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $15.63M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $16.28M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $18.74M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $19.95M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $14.99M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $15.49M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $15.88M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $20.73M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $22.78M 10-Q · filed 2023-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |